company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,33149000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33149000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7608000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,23729000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11287000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,53199000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,53199000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-39733000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-8624000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9368000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,339000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-38650000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-38650000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-585000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,28893000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,28308000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,28308000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-166000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,42691000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,6688000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,237127000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,237127000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3538000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9101000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-217323000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,32443000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,32443000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9170000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19026000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,486000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q4,2009-10-01,2009-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-27710000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-27710000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-20130000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-652000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-12582000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-12582000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-274000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q4,2009-10-01,2009-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8123000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q4,2009-10-01,2009-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,4282000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q4,2009-10-01,2009-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4268000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,295166000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,295166000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12473000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,31400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-225198000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,113841000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,113841000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-35275000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-27740000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19026000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,618000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-81423000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-81423000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-44351000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,30733000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-652000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-14270000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-14270000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1012000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,19160000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,4282000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4268000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,26731000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26731000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2971000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7145000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1908000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,38755000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,38755000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7780000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,266000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7514000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7514000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-24076000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11733000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-12343000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-12343000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,594000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,19492000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-02 15:45:35+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,58039000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-02 15:45:35+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,58039000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-02 15:45:35+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8935000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-02 15:45:35+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,22299000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-02 15:45:35+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7875000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-02 15:45:35+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,81398000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-02 15:45:35+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,81398000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-02 15:45:35+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26105000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-02 15:45:35+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-27740000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-02 15:45:35+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,132000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-02 15:45:35+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-53713000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-02 15:45:35+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-53713000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-02 15:45:35+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-24221000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-02 15:45:35+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,22533000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-02 15:45:35+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1688000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-02 15:45:35+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1688000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-02 15:45:35+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1286000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-02 15:45:35+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,27283000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-30 17:04:46+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,31308000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-30 17:04:46+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31308000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-30 17:04:46+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5964000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-30 17:04:46+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-30 17:04:46+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15154000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-30 17:04:46+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9783000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-30 17:04:46+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,42643000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-30 17:04:46+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,42643000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-30 17:04:46+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18325000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-30 17:04:46+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-27740000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-30 17:04:46+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-30 17:04:46+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-30 17:04:46+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-134000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-30 17:04:46+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-46199000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-30 17:04:46+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-46199000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-30 17:04:46+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-145000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-30 17:04:46+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-30 17:04:46+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-30 17:04:46+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10655000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-30 17:04:46+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10655000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-30 17:04:46+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,692000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-30 17:04:46+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7791000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,26450000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26450000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3928000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-758000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9754000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,11635000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,51009000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,51009000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3915000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,20000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-47315000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,41232000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9978000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9978000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-270000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,16120000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,15850000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,15850000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,308000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,57189000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,7953000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,97030000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,97030000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15792000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,32851000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,15233000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,160906000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,160906000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12843000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-129860000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,53387000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-89318000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-89318000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-649000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,39516000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,38867000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,38867000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-482000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,109973000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,7953000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,307707000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,307707000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15402000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,758000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,32198000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-213725000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,142340000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,142340000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18098000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-20000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-101571000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12155000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,484000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-107050000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-107050000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-20509000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,22744000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10435000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10435000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1064000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,44661000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,4282000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3TTM,2009-10-01,2010-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4268000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,27873000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,27873000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4031000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,161000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-852000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,11730000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,42943000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,42943000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3425000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-58898000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6905000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-55420000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-55420000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-74000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-13803000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,22684000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8807000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8807000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1522000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2148000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-31 16:22:44+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,70580000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-31 16:22:44+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,70580000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-31 16:22:44+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11864000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-31 16:22:44+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,758000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-31 16:22:44+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,23097000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-31 16:22:44+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3598000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-31 16:22:44+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,109897000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-31 16:22:44+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,109897000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-31 16:22:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8928000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-31 16:22:44+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-20000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-31 16:22:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-82545000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-31 16:22:44+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12155000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-31 16:22:44+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-31 16:22:44+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-79340000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-31 16:22:44+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-79340000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-31 16:22:44+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-379000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-31 16:22:44+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,23396000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-31 16:22:44+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,23017000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-31 16:22:44+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,23017000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-31 16:22:44+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-790000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-31 16:22:44+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,52784000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,306565000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,306565000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14342000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,597000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,40195000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-223547000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,138152000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,138152000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22453000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-20000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-42673000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5250000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,752000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-59144000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-59144000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-44511000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,33736000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,60000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-10715000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-10715000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1992000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,66301000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,4282000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2TTM,2009-07-01,2010-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4268000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,21773000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21773000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3991000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,285000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12805000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6608000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,45462000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,45462000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3186000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-20000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-18438000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-21644000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-21644000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-134000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3209000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,399000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3474000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3474000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1250000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,26042000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-03 15:07:28+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,42707000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-03 15:07:28+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,42707000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-03 15:07:28+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7833000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-03 15:07:28+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,597000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-03 15:07:28+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,23949000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-03 15:07:28+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8132000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-03 15:07:28+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,66954000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-03 15:07:28+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,66954000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-03 15:07:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5503000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-03 15:07:28+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-20000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-03 15:07:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-23647000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-03 15:07:28+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5250000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-03 15:07:28+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-23920000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-03 15:07:28+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-23920000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-03 15:07:28+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-305000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-03 15:07:28+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13803000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-03 15:07:28+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,712000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-03 15:07:28+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14210000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-03 15:07:28+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,14210000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-03 15:07:28+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2312000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-03 15:07:28+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,54932000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,20934000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20934000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3842000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,312000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11144000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-14740000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,21492000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,21492000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2317000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5209000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5250000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2276000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2276000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-171000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10594000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,313000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10736000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10736000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1062000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,28890000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,48170000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,48170000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4414000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-24000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12256000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,25971000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,90787000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,90787000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6741000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7358000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,44000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,661000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,661000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-91000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,12944000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12853000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12853000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1590000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,102711000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,538000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,10221000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,175315000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,175315000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,17616000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-24000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,50415000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,26762000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,270084000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,270084000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21982000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-105886000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,94458000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-307000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-33717000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-33717000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-60731000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,60000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,39781000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,39050000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,39050000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1697000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,273720000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,538000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,10221000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,153595000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,153595000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,17130000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-758000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,47913000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12426000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,230306000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,230306000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-19156000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-105866000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-47315000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,128332000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-351000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-44356000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-44356000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-60910000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,60000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,42957000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,42047000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,42047000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,201000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,228198000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,7953000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,65570000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,65570000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4496000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-201000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,19796000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13409000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,76252000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,76252000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5405000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7592000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7592000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-350000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8759000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8409000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8409000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1967000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,90286000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-29 13:26:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,127145000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-29 13:26:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,127145000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-29 13:26:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,13202000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-29 13:26:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,38159000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-29 13:26:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,791000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-29 13:26:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,179297000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-29 13:26:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,179297000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-29 13:26:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15241000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-29 13:26:34+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-105886000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-29 13:26:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,87100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-29 13:26:34+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-351000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-29 13:26:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-34378000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-29 13:26:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-34378000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-29 13:26:34+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-60640000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-29 13:26:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,60000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-29 13:26:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-29 13:26:34+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,26837000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-29 13:26:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,26197000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-29 13:26:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,26197000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-29 13:26:34+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-107000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-29 13:26:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,171009000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,115898000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,115898000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16665000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-396000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,27265000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,37565000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,196997000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,196997000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-17176000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-105866000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-106213000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,122237000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-350000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-107368000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-107368000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-60634000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,60000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-13803000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,56882000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,42445000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,42445000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3690000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,135764000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,7953000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,34745000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,34745000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4389000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,91000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10170000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,29289000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,78684000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,78684000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7614000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-481000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,39100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-10000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,30995000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,30995000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-60290000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-92000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-9685000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,17779000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-52288000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-52104000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,863000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,58438000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-27 13:45:17+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,61575000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-27 13:45:17+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,61575000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-27 13:45:17+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8706000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-27 13:45:17+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,201000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-27 13:45:17+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,18363000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-27 13:45:17+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,14200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-27 13:45:17+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,103045000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-27 13:45:17+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,103045000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-27 13:45:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9836000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-27 13:45:17+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-105886000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-27 13:45:17+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,74100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-27 13:45:17+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-348000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-27 13:45:17+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-41970000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-27 13:45:17+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-41970000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-27 13:45:17+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-60290000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-27 13:45:17+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,60000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-27 13:45:17+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-27 13:45:17+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,18078000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-27 13:45:17+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,17788000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-27 13:45:17+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,17788000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-27 13:45:17+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1860000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-27 13:45:17+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,80723000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,102926000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,102926000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16267000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-202000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,29900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,14884000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,163775000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,163775000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12748000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-105405000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-124651000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,83137000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-340000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-160007000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-160007000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-478000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,60092000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-909000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,39502000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,98207000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,98023000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1577000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,103368000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,7953000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,26830000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26830000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4317000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,110000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8193000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15089000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,24361000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,24361000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2222000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-105405000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,35000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-338000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-72965000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-72965000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,60092000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9685000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,299000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,70076000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,69892000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,997000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,22285000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,80971000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,80971000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6274000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7017000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10695000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,104957000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,104957000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7589000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7590000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7590000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-12127000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-11553000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,11174000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-12506000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-12506000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-886000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,83975000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,4475000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,18272000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,254822000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,254822000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,23887000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,68252000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,63652000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,410613000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,410613000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21846000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-605735000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-4000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-627585000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-627585000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-212949000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-11553000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,355000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,462212000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,73666000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,666376000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,666376000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-768000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,448636000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,4475000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,18272000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,222021000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,222021000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,22027000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-24000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,73491000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,78928000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,396443000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,396443000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20998000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-605735000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7358000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,41000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-619334000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-619334000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-200913000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,355000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,462212000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,75436000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,691735000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,691735000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1472000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,467372000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,538000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,10221000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,92180000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,92180000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6194000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,35827000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7123000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,141324000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,141324000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6239000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6239000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6239000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-67351000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-52000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,30715000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-36688000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-36688000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,919000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,99316000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,173851000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,173851000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,17613000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,61235000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,52957000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,305656000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,305656000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14257000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-605735000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-619995000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-619995000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-200822000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,355000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,462212000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,62492000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,678882000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,678882000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,118000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-25 16:53:43+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,364661000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,195411000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,195411000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,20329000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-225000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,57460000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,58396000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,331371000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,331371000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20164000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-605735000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20358000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,38000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-605503000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-605503000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-133912000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,355000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,462264000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,53480000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,736832000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,736832000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4358000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,458342000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,538000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,10221000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,36258000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,36258000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5544000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13616000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,46109000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,101527000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,101527000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4252000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-306000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4559000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4559000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-127271000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,462264000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,15955000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,350948000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,350948000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1094000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,446822000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,81671000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,81671000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11419000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,25408000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,45834000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,164332000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,164332000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8018000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-605735000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-613756000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-613756000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-133471000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,355000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,462264000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,31777000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,715570000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,715570000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-801000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-26 16:21:02+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,265345000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,193898000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,193898000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,19174000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-134000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,54014000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,41576000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,308528000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,308528000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-23526000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-605910000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,59458000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,29000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-569949000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-569949000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-66931000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,354908000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-9685000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,55304000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,333596000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,333780000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2401000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,69958000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,538000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,10221000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,45413000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,45413000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5875000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11792000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-275000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,62805000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,62805000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3766000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-605429000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-609197000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-609197000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,355000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,15822000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,364622000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,364622000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,293000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-181477000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,252895000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,252895000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,28693000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3235000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6050000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,206476000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,497349000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,497349000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-29329000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1049414000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,60917000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-9315000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1027141000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1027141000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-36220000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-66136000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,173995000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,71639000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,71639000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1491000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-459644000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,2831000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,76165000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18992000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18992000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8454000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2656000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,48722000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,168041000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,208881000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,208881000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8701000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-628426000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,32966000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-9110000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-613271000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-613271000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-12087000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,36603000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,24516000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,24516000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-680000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-380554000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2831000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,76165000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 16:52:52+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,271887000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 16:52:52+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,271887000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 16:52:52+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,20239000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 16:52:52+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,579000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 16:52:52+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-42672000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 16:52:52+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,38435000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 16:52:52+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,288468000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 16:52:52+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,288468000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 16:52:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20628000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 16:52:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-420988000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 16:52:52+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27951000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 16:52:52+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-205000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 16:52:52+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-413870000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 16:52:52+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-413870000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 16:52:52+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-24133000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 16:52:52+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-66136000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 16:52:52+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,137392000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 16:52:52+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,47123000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 16:52:52+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,47123000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 16:52:52+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-811000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 16:52:52+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-79090000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,352858000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,352858000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,26513000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,579000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-35655000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,49130000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,393425000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,393425000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-28217000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-420988000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27951000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-206000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-421460000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-421460000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-36260000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-77689000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,148566000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,34617000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,34617000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1697000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4885000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,4475000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,18272000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,93785000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,93785000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7225000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,554000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-19733000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,62444000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,144275000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,144275000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6616000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-235666000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25949000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-216331000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-216331000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-12034000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,56498000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,44464000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,44464000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1539000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-26053000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-25 12:19:23+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,178102000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-25 12:19:23+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,178102000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-25 12:19:23+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,13014000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-25 12:19:23+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,25000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-25 12:19:23+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-22939000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-25 12:19:23+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-24009000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-25 12:19:23+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,144193000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-25 12:19:23+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,144193000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-25 12:19:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14012000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-25 12:19:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-185322000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-25 12:19:23+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2002000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-25 12:19:23+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-207000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-25 12:19:23+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-197539000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-25 12:19:23+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-197539000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-25 12:19:23+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-12099000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-25 12:19:23+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-66136000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-25 12:19:23+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,80894000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-25 12:19:23+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2659000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-25 12:19:23+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2659000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-25 12:19:23+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2350000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-25 12:19:23+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-53037000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,351253000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,351253000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,25482000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,25000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,19905000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6191000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,390474000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,390474000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-27840000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-185322000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2002000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-208000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-211368000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-211368000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-91577000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-77689000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-52000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,122783000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-46535000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-46535000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2317000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,130254000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,4475000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,18272000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,95885000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,95885000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6748000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,25000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-21208000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,16246000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,97696000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,97696000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8519000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-185322000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2002000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-131000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-191970000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-191970000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-12039000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-31029000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,50035000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6967000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6967000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,811000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-86496000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,291626000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,291626000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,24278000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,54729000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,23672000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,394305000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,394305000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-23573000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-306000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-78000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-23957000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-23957000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-206809000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-46660000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,462212000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,88703000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,297446000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,297446000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4222000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,663572000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,4475000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,18272000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,82217000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,82217000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6266000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1731000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-40255000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,46497000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,46497000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5493000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-76000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5569000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5569000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-60000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-35107000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,30859000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4308000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4308000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3161000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,33459000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,657000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,657000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,47000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-88000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,24000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,640000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,640000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-137000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-705000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,620000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-223000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-223000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-55000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-303000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,365000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-10000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,414000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,2000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,91000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,153420000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,153420000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18605000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-12114000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,106070000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,17403000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,283384000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,283384000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-53121000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-225746000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,221850000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-293000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-57310000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-57310000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-11381000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-19852000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,995000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-30238000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-30238000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4143000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,191693000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,91000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,503580000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,503580000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,28395000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,12114000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-194070000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6597000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,356616000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,356616000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-83879000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-479254000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,398150000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-707000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-165690000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-165690000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-43619000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-283148000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,364005000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,37238000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,37238000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5857000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-02 16:41:31+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,222307000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,484588000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,484588000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,36849000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,14770000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-145348000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,174638000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,565497000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,565497000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-92580000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1107680000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,431116000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-9817000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-778961000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-778961000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-55706000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-283148000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,400608000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,61754000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,61754000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-6537000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-158247000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2831000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,76165000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,177731000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,177731000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9353000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3951000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8496000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,81990000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,281521000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,281521000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22690000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-174355000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,122204000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-733000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-75574000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-75574000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-12038000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-104633000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,57277000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-59394000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-59394000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-6434000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,140119000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,400642000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,400642000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,34721000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,11373000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-173577000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,155092000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,428251000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,428251000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-76506000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1168991000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,334861000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-9082000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-919718000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-919718000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-55702000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-178515000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,399829000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,165612000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,165612000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1436000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-324419000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2831000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,76165000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,166495000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,166495000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9774000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3988000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-100060000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,25953000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,106150000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,106150000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-43456000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-133115000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,176696000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-44000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,81000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,81000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-12039000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-156458000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,145917000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-22580000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-22580000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,109000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,83760000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,325849000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,325849000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,19042000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,8163000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-202566000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-75393000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,75095000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,75095000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-61189000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-304899000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,275946000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,26000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-90116000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-90116000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-31581000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-178515000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,306728000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,96632000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,96632000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,577000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-31 13:50:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,82188000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,330032000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,330032000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,31695000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,7410000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-94725000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,145385000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,419797000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,419797000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-41569000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1221198000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,160167000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-9169000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1111769000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1111769000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-55702000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-53086000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,303947000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,195159000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,195159000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2138000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-494675000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2831000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,76165000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,159354000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,159354000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9268000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4175000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-102506000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-101346000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-31055000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-31055000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-17733000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-171784000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,99250000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,70000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-90197000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-90197000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-19542000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-22057000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,160811000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,119212000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,119212000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,468000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1572000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,144400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,144400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,166600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,319700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,44500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,675200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,675200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-286300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3939300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-534700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1169700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,5400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3585200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3585200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-355500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-327700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3700000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-31700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2985100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2985100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-9000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,66100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,41400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,123200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,66619000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,66619000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,93737000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,83624000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-53122000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,190858000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,190858000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-80076000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,7000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-149914000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,68445000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-79000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-161617000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-161617000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-50790000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-148264000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,17767000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-181287000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-181287000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1136000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-153182000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,41400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,123200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,2017-01-04 17:16:37+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,77781000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,2017-01-04 17:16:37+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,77781000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,2017-01-04 17:16:37+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,72863000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,2017-01-04 17:16:37+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,236076000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,2017-01-04 17:16:37+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,97622000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,2017-01-04 17:16:37+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,484342000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,2017-01-04 17:16:37+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,484342000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,2017-01-04 17:16:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-206224000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,2017-01-04 17:16:37+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3939307000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,2017-01-04 17:16:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-384786000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,2017-01-04 17:16:37+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1101255000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,2017-01-04 17:16:37+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,5479000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,2017-01-04 17:16:37+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3423583000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,2017-01-04 17:16:37+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3423583000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,2017-01-04 17:16:37+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-304710000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,2017-01-04 17:16:37+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-179436000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,2017-01-04 17:16:37+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3700000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,2017-01-04 17:16:37+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-49467000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,2017-01-04 17:16:37+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3166387000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,2017-01-04 17:16:37+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3166387000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,2017-01-04 17:16:37+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-7864000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,2017-01-04 17:16:37+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,219282000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,231201000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,231201000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,91468000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-12114000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,342146000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,115025000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,767726000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,767726000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-259345000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3939307000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-610532000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1323105000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,5186000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3480893000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3480893000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-316091000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-199288000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3700000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-48472000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3136149000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3136149000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-12007000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,410975000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,91000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-183757000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-183757000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,49722000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,141382000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,215739000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,223086000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,223086000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-76053000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-39000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-193601000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,70430000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,4069000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-195194000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-195194000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1105000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-92009000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-91914000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-185028000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-185028000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1706000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-158842000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-29 16:11:04+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,261538000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-29 16:11:04+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,261538000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-29 16:11:04+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,23141000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-29 16:11:04+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,94694000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-29 16:11:04+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-118117000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-29 16:11:04+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,261256000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-29 16:11:04+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,261256000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-29 16:11:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-130171000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-29 16:11:04+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3939268000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-29 16:11:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-191185000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-29 16:11:04+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1030825000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-29 16:11:04+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1410000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-29 16:11:04+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3228389000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-29 16:11:04+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3228389000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-29 16:11:04+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-303605000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-29 16:11:04+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-87427000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-29 16:11:04+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3700000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-29 16:11:04+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,42447000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-29 16:11:04+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3351415000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-29 16:11:04+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3351415000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-29 16:11:04+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-6158000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-29 16:11:04+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,378124000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,592689000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,592689000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,51099000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-8163000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,209260000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-18724000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,826161000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,826161000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-205982000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3939268000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-591286000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1374879000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,384000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3361273000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3361273000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-327024000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-211912000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3700000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,100719000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3261783000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3261783000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-16735000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,709936000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,91000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,170215000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,170215000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12563000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-3178000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,101391000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-42769000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,238222000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,238222000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-73096000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3939268000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-22630000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,854569000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,459000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3179966000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3179966000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-291302000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-27401000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3700000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-34956000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3346341000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3346341000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,712000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,405309000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,91323000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,91323000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10578000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3178000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-6697000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-75348000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,23034000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,23034000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-57075000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-168555000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,176256000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,951000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-48423000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-48423000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-12303000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-60026000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,77403000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5074000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5074000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-6870000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-27185000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,588969000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,588969000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,48310000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-997000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7809000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,49998000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,694089000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,694089000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-176342000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-701771000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,697006000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-119000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-181226000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-181226000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-47761000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-340969000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,281592000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-107138000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-107138000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-17338000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,388387000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,91000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,399400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,399400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,396400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,287100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1086300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1086300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-332700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-675600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,721800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-287600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-287600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-382700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-430600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-22900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-836200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-836200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-6600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-44100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,79600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,37700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,93400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,93400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,101400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,126100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,62400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,383300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,383300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-106700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-13600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,236800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,114400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,114400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-202700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-30600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-50900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-284200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-284200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-9600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,203900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,79600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,37700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 16:06:12+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,306000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 16:06:12+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,306000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 16:06:12+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,295000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 16:06:12+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,161000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 16:06:12+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-59000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 16:06:12+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,703000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 16:06:12+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,703000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 16:06:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-226000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 16:06:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-662000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 16:06:12+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,485000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 16:06:12+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 16:06:12+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-402000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 16:06:12+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-402000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 16:06:12+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-180000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 16:06:12+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-400000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 16:06:12+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,28000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 16:06:12+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-552000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 16:06:12+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-552000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 16:06:12+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 16:06:12+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-248000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,372619000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,372619000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,388737000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,244624000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-112122000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,893858000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,893858000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-306076000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,7000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-811914000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,553445000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,921000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-563617000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-563617000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-230790000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-548264000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,45767000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-733287000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-733287000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1864000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-401182000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,41400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,123200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,94000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,94000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,100000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,51000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,45000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,290000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,290000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-95000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-163000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,191000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-66000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-66000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-69000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-61000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-61000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,164000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 16:10:01+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,212000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 16:10:01+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,212000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 16:10:01+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,195000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 16:10:01+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,110000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 16:10:01+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-104000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 16:10:01+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,413000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 16:10:01+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,413000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 16:10:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-131000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 16:10:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-499000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 16:10:01+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,294000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 16:10:01+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 16:10:01+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-336000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 16:10:01+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-336000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 16:10:01+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-180000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 16:10:01+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-331000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 16:10:01+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,20000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 16:10:01+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-491000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 16:10:01+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-491000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 16:10:01+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 16:10:01+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-412000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,94862000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,94862000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,338459000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,335006000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,58617000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,826944000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,826944000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-287129000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-32000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-842515000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,432875000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,3990000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-692811000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-692811000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-231895000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-571273000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-54147000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-857315000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-857315000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-842000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-724024000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,41400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,123200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,120000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,120000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,98000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,49000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-28000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,239000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,239000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-67000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-288000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-330000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-330000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-34000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,16000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-19000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-19000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-112000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,92000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,92000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,97000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,61000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-76000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,174000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,174000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-64000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-211000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,269000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-179000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-297000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-472000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-472000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-300000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,145077000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,145077000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,253022000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-3178000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,387397000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,43848000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,826166000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,826166000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-293225000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3939300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-577145000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1262444000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,4449000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3542777000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3542777000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-522197000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-564674000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3700000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-105103000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2508026000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2508026000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1870000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-206715000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,41400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,123200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,443300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,443300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,496700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,369000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-193400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1115600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1115600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-357300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1658700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1097600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-918300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-918300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-185900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-463600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,52900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-596600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-596600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,17700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-381600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,95300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,162100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,30000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,30000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,185100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,95300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-52300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,258100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,258100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-88500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-70600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,159500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-44200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-165100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-16100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-225400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-225400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,34300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,95300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,162100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-24 16:27:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,413300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-24 16:27:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,413300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-24 16:27:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,311600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-24 16:27:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,273700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-24 16:27:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-141100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-24 16:27:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,857500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-24 16:27:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,857500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-24 16:27:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-268800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-24 16:27:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1588100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-24 16:27:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,938100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-24 16:27:34+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-24 16:27:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-918700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-24 16:27:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-918700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-24 16:27:34+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-141700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-24 16:27:34+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-298500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-24 16:27:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-24 16:27:34+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,69000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-24 16:27:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-371200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-24 16:27:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-371200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-24 16:27:34+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,16500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-24 16:27:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-415900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,506700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,506700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,413000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,399800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-78700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1240800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1240800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-375500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1601700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1174900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-804300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-804300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-344400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-329100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,18100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-655400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-655400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,6900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-212000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,79600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,37700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,78000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,78000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,110400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,141100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-60000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,269500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,269500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-93300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-455200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,378400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-170200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-170200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-44300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-59600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-95500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-95500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:40:18+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,335300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:40:18+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,335300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:40:18+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,201200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:40:18+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,132600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:40:18+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-81100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:40:18+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,588000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:40:18+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,588000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:40:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-175500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:40:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1132900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:40:18+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,559700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:40:18+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:40:18+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-748500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:40:18+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-748500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:40:18+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-97400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:40:18+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-238900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:40:18+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:40:18+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,60600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:40:18+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-275700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:40:18+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-275700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:40:18+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,12000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:40:18+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-424200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,522700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,522700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,402600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,309700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,26300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1261300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1261300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-377200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1309500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,987500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-700100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-700100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-300100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-338500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,17700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-620900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-620900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-56300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,79600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,37700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,165200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,165200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,101600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,80900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-67600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,280100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,280100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-101100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-429500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,277200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-253200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-253200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-49500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-170800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,13300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-207000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-207000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,8800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-171300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,170100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,170100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,99600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,51700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,307900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,307900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-74400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-703400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,282500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-495300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-495300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-47900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-68100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,47300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-68700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-68700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-252900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,477500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,477500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,399000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,277800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,65900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1220200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1220200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-343100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1168000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,735300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-776900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-776900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-251600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-201700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,20400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-432900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-432900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-7400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,79600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,37700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,77600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,77600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,405300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,227900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-284800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,426000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,426000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-213000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-805100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1485800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,470500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,470500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-314700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-85000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,250000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,47300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-102400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-102400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-11200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,782900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,90900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,163900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-45000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-45000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,98400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,81700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-51700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,83400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,83400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-42400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-24700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,120100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,52200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,52200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,138100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,90900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,163900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-23 07:56:30+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,122600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,122600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,306900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,146200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-233100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-23 07:56:30+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,342600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-23 07:56:30+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,342600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-170600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-780400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1365700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,3600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-23 07:56:30+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,418300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-23 07:56:30+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,418300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-311900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-85000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,250000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,41400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-23 07:56:30+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-105500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-23 07:56:30+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-105500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-23 07:56:30+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-10600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-23 07:56:30+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,644800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,152600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,152600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,492000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,241500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-285400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,600700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,600700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-259100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-851000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1525200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,3600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,418700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,418700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-356100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-250100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,250000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,25300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-330900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-330900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-9400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,679100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,95300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,162100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,330900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,330900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,104900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,25900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-74600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,387100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,387100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-41200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-160100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,305000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,104700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,104700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,16800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,11000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,498300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-24 08:00:01+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-208300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-208300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,202000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,120300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-158500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-24 08:00:01+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-44500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-24 08:00:01+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-44500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-129400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-620300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1060700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-24 08:00:01+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,313600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-24 08:00:01+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,313600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-306100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-85000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,250000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,24600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-24 08:00:01+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-116500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-24 08:00:01+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-116500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-24 08:00:01+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-6100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-24 08:00:01+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,146500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-100300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-100300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,497500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,356700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-270800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,483100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,483100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-311200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1146100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1598600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,143800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,143800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-394600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-309700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,250000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,16900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-437400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-437400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,189100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,95300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,162100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-457400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-457400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,100500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,167900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-154800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-343800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-343800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-62800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-272300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,902900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,568300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,568300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-258200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,250000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,15200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-12400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,219100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,249100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,249100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,101500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-47600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,299300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,299300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-66600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-348000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,157800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-254700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-254700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-47900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-85000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,9400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-123500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-123500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,6300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-72600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,522300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,522300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,498600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,269700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-183600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1107000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1107000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-349500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1303300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,972900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-677700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-677700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-185900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-480500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,15000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-651400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-651400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,20800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-201300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,95300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,162100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,889000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,889000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,90600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,88700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-551200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,517100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,517100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-30000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-42800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,129200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,56300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,56300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-33900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-32500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-59700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-59700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,6900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,520600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,72600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,187900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2404300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2404300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,376800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,124000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-820200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2084900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2084900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-154700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-16000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-171100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,351600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-353000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-416000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,29900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-739100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-739100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1356300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,72600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,187900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1470300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1470300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,384600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,117000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-320700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1651200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1651200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-167100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-16000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-153000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,342500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-321900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-383500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,29100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-676300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-676300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-6700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,973800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,90900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,163900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,467600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,467600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,92500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-78600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,118000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,599500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,599500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-41900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-8000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-32500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,74100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-34000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-334600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-365900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-365900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-6800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,218300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-23 07:56:30+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1515300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1515300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,286200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,35300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-269000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-23 07:56:30+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1567800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-23 07:56:30+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1567800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-124700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-16000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-128300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,222400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-23 07:56:30+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-46600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-23 07:56:30+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-46600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-319100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-383500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-23 07:56:30+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,23200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-23 07:56:30+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-679400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-23 07:56:30+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-679400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-23 07:56:30+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-6100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-23 07:56:30+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,835700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1333600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1333600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,397000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,221500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-513300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1438800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1438800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-166400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-8000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-280600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,573400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,118800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,118800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-293700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-48900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,43200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-299400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-299400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1253800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,90900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,163900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,459800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,459800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,96500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,86000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-103900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,538400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,538400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-46800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-46200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,52000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-41000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-41000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-33800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-37600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-61100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-61100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,438400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-24 08:00:01+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1047700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1047700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,193700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,113900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-387000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-24 08:00:01+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,968300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-24 08:00:01+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,968300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-82800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-8000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-95800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,148300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-24 08:00:01+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-38100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-24 08:00:01+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-38100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-285100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-48900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-24 08:00:01+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,20500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-24 08:00:01+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-313500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-24 08:00:01+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-313500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-24 08:00:01+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-24 08:00:01+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,617400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,587900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,587900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,97200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,27900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-283100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,429900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,429900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-36000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-8000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-49600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,96300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-251300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-11300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-252400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-252400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,179000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,416400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,416400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,401000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,303400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-564200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,556600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,556600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-182400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-8000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-506700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1424300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,728100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,728100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-518100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-11300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,250000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,48100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-231300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-231300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-18900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1034500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,90900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,163900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2374000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2374000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,368900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,168700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-707000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2204600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2204600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-130900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-845700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-182300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,400000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-759200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-759200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-135600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-511800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,22500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-624900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-624900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-11000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,809500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,72600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,187900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,557600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,557600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,89300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,72600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-169900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,549600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,549600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-837700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-60800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,144700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-766000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-766000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-33900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-107100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-138200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-138200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-13200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-367800000.0
